
KabaFusion
KabaFusion is a medical company that specializes in intravenous immunoglobulin and home-infusion iv therapy.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Growth Equity VC | |
Total Funding | 000k |
Related Content
KabaFusion is a healthcare company that provides home infusion therapies. The company operates a network of home infusion specialty pharmacies across the United States, offering services for a wide range of prescribed therapies.
KabaFusion specializes in intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) therapies. The company also provides home nursing support for its patients. Its business model is centered on providing patient-focused care, with an emphasis on positive clinical outcomes. KabaFusion serves patients who require long-term, chronic, or acute infusion therapies that can be administered in a home setting.
In a recent strategic move, KabaFusion acquired the home infusion assets of Lincare, a subsidiary of Linde plc. This acquisition is expected to expand KabaFusion's service offerings and patient reach.
Keywords: home infusion, specialty pharmacy, intravenous immunoglobulin, subcutaneous immunoglobulin, nursing support, healthcare services, patient care, medical therapies, chronic care, acute care